首页> 外文期刊>The Biochemical Journal >Hepcidin expression in mouse retina and its regulation via lipopolysaccharide/Toll-like receptor-4 pathway independent of Hfe.
【24h】

Hepcidin expression in mouse retina and its regulation via lipopolysaccharide/Toll-like receptor-4 pathway independent of Hfe.

机译:Hepcidin在小鼠视网膜中的表达及其通过脂多糖/ Toll样受体4途径的独立于Hfe的调控。

获取原文
获取原文并翻译 | 示例
           

摘要

Hepcidin is a hormone central to the regulation of iron homeostasis in the body. It is believed to be produced exclusively by the liver. Ferroportin, an iron exporter, is the receptor for hepcidin. This transporter/receptor is expressed in Muller cells, photoreceptor cells and the RPE (retinal pigment epithelium) within the retina. Since the retina is protected by the retinal-blood barriers, we asked whether ferroportin in the retina is regulated by hepcidin in the circulation or whether the retina produces hepcidin for regulation of its own iron homeostasis. Here we show that hepcidin is expressed robustly in Muller cells, photoreceptor cells and RPE cells, closely resembling the expression pattern of ferroportin. We also show that bacterial LPS (lipopolysaccharide) is a regulator of hepcidin expression in Muller cells and the RPE, both in vitro and in vivo, and that the regulation occurs at the transcriptional level. The action of LPS on hepcidin expression is mediated by the TLR4 (Toll-like receptor-4). The upregulation of hepcidin by LPS occurs independent of Hfe (human leukocyte antigen-like protein involved in Fe homeostasis). The increase in hepcidin levels in retinal cells in response to LPS treatment is associated with a decrease in ferroportin levels. The LPS-induced upregulation of hepcidin and consequent down-regulation of ferroportin is associated with increased oxidative stress and apoptosis within the retina in vivo. We conclude that retinal iron homeostasis may be regulated in an autonomous manner by hepcidin generated within the retina and that chronic bacterial infection/inflammation of the retina may disrupt iron homeostasis and retinal function.
机译:铁调素是调节体内铁稳态的关键激素。据信它仅由肝脏产生。铁出口铁转运蛋白是铁调素的受体。该转运蛋白/受体在视网膜内的穆勒细胞,感光细胞和RPE(视网膜色素上皮)中表达。由于视网膜受到视网膜血液屏障的保护,因此我们询问视网膜中的铁转运蛋白是否受循环中铁调素的调节,或者视网膜是否产生铁调素来调节自身的铁稳态。在这里,我们显示hepcidin在Muller细胞,感光细胞和RPE细胞中表达强烈,与铁转运蛋白的表达模式非常相似。我们还显示,细菌LPS(脂多糖)是Muller细胞和RPE中hepcidin表达的调节剂,无论是在体内还是体外,这种调节都发生在转录水平。 LPS对铁调素表达的作用是由TLR4(Toll样受体4)介导的。 LPS对hepcidin的上调独立于Hfe(参与Fe动态平衡的人白细胞抗原样蛋白)。响应LPS治疗,视网膜细胞中铁调素水平的增加与铁转运蛋白水平的降低有关。 LPS诱导的铁调素上调和随之而来的铁转运蛋白的下调与体内视网膜内氧化应激和细胞凋亡的增加有关。我们得出的结论是,视网膜内铁稳态可能受到视网膜内产生的铁调素的自主调节,并且慢性细菌感染/视网膜发炎可能会破坏铁内稳态和视网膜功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号